Taiwan Advance Bio-Pharmaceutical (ROCO:4186) LT-Debt-to-Total-Asset : 0.12 (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Taiwan Advance Bio-Pharmaceutical LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Taiwan Advance Bio-Pharmaceutical's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.12.

Taiwan Advance Bio-Pharmaceutical's long-term debt to total assets ratio declined from Dec. 2022 (0.15) to Dec. 2023 (0.12). It may suggest that Taiwan Advance Bio-Pharmaceutical is progressively becoming less dependent on debt to grow their business.

Taiwan Advance Bio-Pharmaceutical LT-Debt-to-Total-Asset Historical Data

The historical data trend for Taiwan Advance Bio-Pharmaceutical's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Advance Bio-Pharmaceutical LT-Debt-to-Total-Asset Chart

Taiwan Advance Bio-Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.24

0.15

0.16

0.15

0.12

Taiwan Advance Bio-Pharmaceutical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.16	0.17	0.15	0.14	0.12

Taiwan Advance Bio-Pharmaceutical LT-Debt-to-Total-Asset Calculation

Taiwan Advance Bio-Pharmaceutical's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	86.89	/	748.571
	=	0.12

Taiwan Advance Bio-Pharmaceutical's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	86.89	/	748.571
	=	0.12

Taiwan Advance Bio-Pharmaceutical (ROCO:4186) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Taiwan Advance Bio-Pharmaceutical LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Taiwan Advance Bio-Pharmaceutical's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Advance Bio-Pharmaceutical Inc (ROCO:4186) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

12F., No.25, Ln. 169, Kangning Street, Xizhi Dist, New Taipei City, TWN, 22180

Website

http://www.abc-residue.com

Taiwan Advance Bio-Pharmaceutical Inc operates in the food safety industry. The company's product includes Food safety test kit, Animal test kit, Pesticide test kit, Mycotoxin test kit, Nuleic acid extraction kit.

Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Headlines

No Headlines